Jul 07, 2020
72:61
For every 61 shares held, investors received 72. The price per share adjusted from $0.03 to $0.03.
The split itself did not change the total investment value.
Arovella Therapeutics Limited (ASX:ALA) operates in the Pharmaceuticals: major industry.
Arovella Therapeutics Limited company overviewArovella Therapeutics Limited's most recent stock split was on July 7, 2020. It was a 72-for-61 forward split, so shareholders received 72 shares for every 61 they held.
Arovella Therapeutics Limited (ASX:ALA) has split its stock 4 times: a 12-for-11 split on July 6, 2018, a 20-for-19 split on June 5, 2019, a 1-for-25 reverse split on November 14, 2019, and a 72-for-61 split on July 7, 2020.
Arovella Therapeutics Limited has split its stock 4 times. This history records 4 splits between July 6, 2018 and July 7, 2020.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Arovella Therapeutics Limited's 72-for-61 split on July 7, 2020, every 61 shares became 72 shares.
Arovella Therapeutics Limited has not announced a new split in our records. Its most recent split was on July 7, 2020, 6 years ago. Companies announce splits in advance, and any new ASX:ALA split will appear on this page.
Already premium?